Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > While we wait...
View:
Post by N0taP00p on Mar 16, 2023 10:32am

While we wait...

Can someone give one or two examples of Canadian penny stocks that have actually succeeded big time?  My last two proved disastrous. Titan Medical and  Sona Nanotech. Just couldn't deliver.  Innovation didn't meet execution.   I also had a few rare earth stocks.  Ended up selling at a loss.  TLT will be my last investment in Canadian stocks, unless I come out ahead.  It's been over ten years of a lethargic and plodding  pulserate. They do seem to have the goods and seem ready to take off, but that's a story I've heard before.  Blind faith is for fools.
Comment by Rumpl3StiltSkin on Mar 16, 2023 11:15am
Poop, Remember Bre-X? Ha Ha...
Comment by N0taP00p on Mar 16, 2023 11:26am
Rumpl3... Didn't buy into that. :).  Those guys always put out NRs about finding  big deposits in some foreign country. 
Comment by DJDawg on Mar 16, 2023 11:30am
One thing that TLT has always got going for it is the fact that the study investigators are in charge of the data and, as academic clinicians, have not interest in being part of some fraud. Granted TLT has done a great job of presenting the data in very confusiong graphs and tables over time. But never misled. Bre-ex was always a fraud. TLT is safe that way. Just suffers from lots of other ...more  
Comment by PBMTORBUST on Mar 16, 2023 12:23pm
Well most academics are honest you are sadly mistaken there's no risk that data isn't fudged. There's a lot at stake and pressure on them and there are many many cases of fraudulent publsihed research. I am not saying this is the case wiht TLT but saying academia never commits fraud is inaccurate.
Comment by Eoganacht on Mar 16, 2023 12:48pm
You would need the coordinated efforts of 11 top urologists in order to fudge the data. These guys are doctors with cancer patients under their care. They would need to be comic book villains to deny them a treatment that could save their bladders.
Comment by DJDawg on Mar 16, 2023 12:55pm
Academics fudge lab data all the time. Especially when competing for lifetime tenure roles in universities.I have been involved in research in thyroid cancer and there is no skin in the game for fudging this kind of patient data for the clinician researchers.
Comment by plantrader on Mar 16, 2023 11:16am
From a stock price standpoint alone, to your point it does seem like something good shoudl happen eventually even if it's not a moonshot. As long as the clinical trial data doesn't take a turn for the worse for whatever reason, or as long as they haven't designed the trial incorrectly, etc, but it seems like they've been through most of those speedbumps and corrected as needed.
Comment by N0taP00p on Mar 16, 2023 11:33am
That's exactly my hope, Plantrader. Bad execution, and inability to generate excitement in the right circles is what worries me about stocks like these, despite the great science.  Yes, hope they've learned their lessons. Hope they make a solid case to the FDA. Maybe Eoga can help them state their numbers. God knows the world needs alternatives to BCG. 
Comment by DJDawg on Mar 16, 2023 11:48am
Keep in mind that one of the weird quirks of this stock is that RDW was put in penalty box for the last 5 years for excessive enthusiasm about TLT ( in this case, the likely success of a laser used by physio and chiropractors). If he were not in penalty box, he may have been out there doing the PR game a bit more. The most recent CEO is the lab and science guy who is clearly doing it as a ...more  
Comment by N0taP00p on Mar 16, 2023 11:59am
DjDawg, I hear you. But does he have the brand and oomph to go beyond the small TV shows and online interviews that a few hundred people watch or see?  Having a BTD would be the hammer to help him become Thor.  Got  carried away there, sorry.  
Comment by DJDawg on Mar 16, 2023 12:10pm
who knows. SESN managed to get out there and get it's market cap up to 10xTLT with a 17% CR at 12m. One would hope that it wouldn't take a Norse god to do this effort..... Doesn't help that that the vast pool of US investors would be weary of an OTC stock.
Comment by 2b7f6fab on Mar 16, 2023 2:05pm
Novagold I bought I think back in 2003 @ .25 cents then sold for something like $3. After then it went to like $19. If you have the goods they will come.  Anyone can buy TLT for under .30 cents.  Who here wouldn't like to see it hit $19 ?
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250